跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CIROFAXIN ciprofloxacin 750mg (as hydrochloride monohydrate) tablet blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
CIROFAXIN ciprofloxacin 750mg (as hydrochloride monohydrate) tablet blister pack
Approved
STANDARD
CIROFAXIN ciprofloxacin 750mg (as hydrochloride monohydrate) tablet blister pack
Strides Pharma Science Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
e4bb69fa0ef98897
Company
Strides Pharma Science Pty Ltd
Type
Standard
Approval Details
Approval Id
e4bb69fa0ef98897
Product Name
CIROFAXIN ciprofloxacin 750mg (as hydrochloride monohydrate) tablet blister pack
Artg Id
114045
Artg Name
CIROFAXIN ciprofloxacin 750mg (as hydrochloride monohydrate) tablet blister pack
Sponsor
Strides Pharma Science Pty Ltd
Company Detail Path
/organization/strides-pharma-science-pty-ltd
Artg Date
2004-11-05
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
e4bb69fa0ef98897
Type
Standard
Back to TGA Approvals
